Similar companies
Income Statement (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Revenue | 1.73B | 0.5% |
| Gross Profit | 560M | 1.5% |
| Cost of Revenue | 1.17B | 0% |
| Operating expense | 353M | 0.6% |
| Net Income | 115M | 5.5% |
| EBITDA | 357M | 2.9% |
Balance Sheet (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Total Assets | 11.2B | 1.9% |
| Total Liabilities | 5.2B | 3.5% |
| Total Equity | 5.73B | 0.3% |
| Shares Outstanding | 1.29B | 0% |
Cash Flow (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Cash from operations | 272M | 1.5% |
| Cash from financing | -217M | 4.4% |
EPS
Financial Highlights for ICL Israel Chemicals in Q2 '24
ICL Israel Chemicals reported a revenue of 1.73B, which is a 0.5% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 560M, marking a 1.5% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 1.17B, a -0% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 353M, showing a 0.6% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 115M, showing a 5.5% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 357M, showing a 2.9% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for ICL Israel Chemicals with growth in revenue, gross profit, and net income. Higher operating expenses might indicate increased investments or potential inefficiencies.
